Maintenance fees coming due
19 maintenance fees come due in the 12 months from Nov 20, 2026, the next on Jan 30, 2027. Unpaid by Jul 30, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 10,363,273 | Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy In force Fee due Jan 30, 2027 Lapses if unpaid Jul 30, 2027 · Low confidence | Iovance Biotherapeutics, Inc. | In force | Jan 30, 2027 | Jul 30, 2027 | Low confidence | |
| US 11,713,446 | Processes for Generating Til Products Enriched for Tumor Antigen-Specific T-Cells In force Fee due Feb 1, 2027 Lapses if unpaid Aug 2, 2027 · High confidence | Iovance Biotherapeutics, Inc. | In force | Feb 1, 2027 | Aug 2, 2027 | High confidence | |
| US 10,398,734 | Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy In force Fee due Mar 3, 2027 Lapses if unpaid Sep 3, 2027 · High confidence | Iovance Biotherapeutics, Inc. | In force | Mar 3, 2027 | Sep 3, 2027 | High confidence | |
| US 10,415,015 | Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion In force Fee due Mar 17, 2027 Lapses if unpaid Sep 17, 2027 · High confidence | Iovance Biotherapeutics, Inc. | In force | Mar 17, 2027 | Sep 17, 2027 | High confidence | |
| US 10,420,799 | Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy In force Fee due Mar 24, 2027 Lapses if unpaid Sep 24, 2027 · Low confidence | Iovance Biotherapeutics, Inc. | In force | Mar 24, 2027 | Sep 24, 2027 | Low confidence | |
| US 10,463,697 | Processes for Production of Tumor Infiltrating Lymphocytes and Uses of Same in Immunotherapy In force Fee due May 5, 2027 Lapses if unpaid Nov 5, 2027 · High confidence | Iovance Biotherapeutics, Inc. | In force | May 5, 2027 | Nov 5, 2027 | High confidence | |
| US 11,819,517 | Methods of Using Tumor Infiltrating Lymphocytes in Double-Refractory Melanoma In force Fee due May 21, 2027 Lapses if unpaid Nov 22, 2027 · Medium confidence | Iovance Biotherapeutics, Inc. | In force | May 21, 2027 | Nov 22, 2027 | Medium confidence | |
| US 10,517,894 | Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes In force Fee due Jun 30, 2027 Lapses if unpaid Jan 3, 2028 · Low confidence | Iovance Biotherapeutics, Inc. | In force | Jun 30, 2027 | Jan 3, 2028 | Low confidence | |
| US 11,857,573 | Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes In force Fee due Jul 2, 2027 Lapses if unpaid Jan 3, 2028 · Medium confidence | Iovance Biotherapeutics, Inc. | In force | Jul 2, 2027 | Jan 3, 2028 | Medium confidence | |
| US 11,865,140 | Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes In force Fee due Jul 9, 2027 Lapses if unpaid Jan 10, 2028 · Medium confidence | Iovance Biotherapeutics, Inc. | In force | Jul 9, 2027 | Jan 10, 2028 | Medium confidence | |
| 9 more maintenance fees coming due in the 12 months from Nov 20, 2026 · Pro | |||||||
10 of 19 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.